MRK Merck & Co
- 131.225
- +0.025+0.02%
Merck & Co News
Merck & Co | 8-K: Merck Announces First-Quarter 2024 Financial Results
Merck & Co | ARS: Annual Report to Security Holders
Merck & Co | DEFA14A: Others
Merck & Co | DEF 14A: Definitive information statements
Merck & Co | 10-K/A: Annual report (Amendment)
Merck & Co | 3: Initial statement of beneficial ownership of securities-Officer Larson Betty D
Merck & Co | PX14A6G: Notice of exempt solicitation
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director WENDELL PETER C
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Seidman Christine E
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director GLOCER THOMAS H
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Coe Mary Ellen
Merck & Co | PX14A6G: Notice of exempt solicitation
Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Merck & Co | 4: Statement of changes in beneficial ownership of securities-10% Owner Merck & Co., Inc.
Merck & Co | 10-K: Annual report
Merck & Co | 8-K: Peter C. Wendell Gave Notice to Merck & Co., Inc. Of His Intention to Retire from the Board of Directors of the Company as of the Company’s 2024 Annual Meeting of Shareholders on May 28, 2024
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Litchfield Caroline
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Davis Robert M
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Romanelli Joseph
Analysis
Price Target
No Data
